On March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will take place June 27-28. The FDA wants to know more about the risk and benefits of the systems, their use, and the management of patients. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder